ANNEX
REPORTS OF THE SCIENCE AND TECHNOLOGY COMMITTEE IN
THIS PARLIAMENT
Session 1997-1998
First Report: The Implications of the Dearing
Report for the Structure and Funding of University Research, HC
303-I, published 2 April 1998.
Second Report: The Year 2000—Computer
Compliance, HC 342-I, published 7 April 1998. (Government's
response published as Cm 3944, July 1998.)
Third Report: Glaxo Wellcome and SmithKline
Beecham: The Merger Proposals, HC 627, published 16 June 1998.
Fourth Report: The Cloning of Animals
from Adult Cells, HC 1039, published 4 August 1998.
Fifth Report: British Biotech, HC, 888-I,
published 17 August 1998.
Sixth Report: Science and the Comprehensive
Spending Review, HC 1040, published 1 December 1998.
1st Special Report: The Government's
Response to the Science and Technology Committee's Fourth Report,
Session 1996-97, The Research Council System: Issues for the Future,
HC 302, published 11 December 1997.
2nd Special Report: The Government's
Response to the Science and Technology Committee's Third Report,
Session 1996-97, The Natural Environment Research Council and
Research into Climate Change, HC 306, published 11 December
1997.
3rd Special Report: The Government's
Response to the Science and Technology Committee's First Report,
Session 1997-98, the Implications of the Dearing Report for the
Structure and Funding of University Research, HC 799, published 30 June 1998.
4th Special Report: The Government's
Response to the Science and Technology Committee's Fifth Report
Session 1997-98 British Biotech, HC 1185, published 3 December 1998.
Session 1998-1999
First Report: Scientific Advisory System: Genetically
Modified Foods, HC 286-I, published 18 May 1999.
(Government's response published as Cm 4427, November
1999.)
Second Report: The National Endowment
for Science, Technology and the Arts, HC 472, published 22
July 1999.
Third Report: Scientific Advisory System:
Mobile Phones and Health, HC 489, published 22 September 1999.
(NB Government's response published as Cm 4551, December 1999.)
Fourth Report: The Regulation of the
Biotechnology Industry, HC 535, published 13 December 1999.
1st Special Report: Government
Response to the Sixth Report of the Science and Technology Committee
(Session 1997-98) on Science and the Comprehensive Spending Review,
HC 234, published 23 February 1999.
2nd Special Report: Government
Response to the Second Report from the Committee on the National
Endowment for Science, Technology and the Arts, HC 822, published
11 November 1999.
Session 1999-2000
First Report: The Year 2000—Computer
Compliance: Follow-Up, HC 37, published 9 December
1999.
Second Report: Engineering and Physical Sciences
Based Innovation, HC 195-I, published 9 February 2000.
Third Report: Scientific Advisory System:
Diabetes and Driving Licences, HC 206-I, published March
2000.
(Government's response published as Cm
4723, May 2000.)
Fourth Report: Glaxo Wellcome and SmithKline
Beecham, HC 207-I, published 11 April 2000.
Fifth Report: Government Expenditure on Research
and Development: The Forward Look, HC 196-I, published 19
April 2000.
Sixth Report: Cancer Research—A
Fresh Look, HC 332-I, published 27 July 2000.
(Government's response published as Cm 4928, November
2000.)
Seventh Report: The Government's Expenditure
on Research and Development: The Forward Look—The Government's
Reply, HC 723, published 16 August 2000.
1st Special Report: Government
Response to the Second Report of the Science and Technology Committee
(Session 1999-2000) on Engineering and Physical Sciences Based
Innovation, HC 451, published 8 May 2000.
2nd Special Report: Joint Working
with the Lords Science and Technology Committee, HC 980, published
16 November 2000.
3rd Special Report: Government
Response to the Seventh Report of the Science and Technology Committee
on the Government's Expenditure on Research and Development: The
Forward Look—The Government's Reply, HC 981, published
23 November 2000.
| 
